CAP ORGAN TECHNOLOGY
Better than cell-based assays, 3D tissue assemblies provide the best compromise between ease of use and in vivo-like drug responses. We manufacture human skin, bone, lung and intestine which is important for use as a model to develop medical treatments, consumer products and cosmetics.
Dr. Hoeffler made a pivotal contribution in 2000 with his scientific paper entitled “Spontaneous Cell Sorting of Fibroblasts and Keratinocytes Creates an Organotypic Human Skin Equivalent", advancing the concept of triggering cells to migrate into correct position, rather than attempting to position them using ‘inkjet’ printing technology, or consecutive layering. We received criticism at the time, but this is now used as the platform for organ creation in some of the best research.
Below: our technology yields full-thickness skin. See gallery for more images of the results of our CAP organ technology.